What kind of medicine is mitotane? Comprehensive analysis of treatment principles and applicable groups

Mitotane is a chemotherapy drug mainly used to treat adrenocortical carcinoma (ACC), a rare but extremely aggressive cancer. Mitotane is also commonly used to treat other types of adrenal gland disorders, such as some forms of hyperadrenocorticism (such as Cushing's syndrome). Mitotane works by inhibiting the function of the adrenal cortex, thereby controlling tumor growth.

Mitotane's mechanism of action is primarily by damaging adrenocortical cells, resulting in the loss of function of these cells. It inhibits the secretion of adrenocortical hormones such as cortisol and aldosterone, thereby reducing the impact of these hormones on the body. Adrenocortical cancer is often accompanied by an imbalance in hormone secretion. Mitotane helps reduce tumor proliferation and deterioration by reducing hormone secretion from the adrenal glands. In addition, mitotane can destroy tumor cells and inhibit their growth through direct cytotoxicity.

Mitotane is mainly indicated for patients with adrenocortical cancer, especially those whose disease is more severe and whose tumors cannot be completely removed by surgery. Mitotane also has a certain therapeutic effect in patients with recurrent adrenocortical cancer. In these patients, mitotane not only helps control the growth of cancer cells, but also relieves some clinical symptoms caused by abnormal hormone levels.

In addition, mitotane also has therapeutic effects on certain diseases caused by adrenal hyperactivity, such as Cushing's syndrome. Cushing's syndrome is a group of symptoms caused by excessive cortisol secretion. Mitotane helps improve patients' symptoms by reducing cortisol secretion and reduces the harm to the body caused by long-term excessive cortisol.

However, the use of mitotane needs to be strictly monitored by a doctor because it may cause a series of side effects, including nausea, vomiting, fatigue, abnormal liver function, etc., and the dose needs to be adjusted according to the patient's tolerance.

In summary, mitotane is a therapeutic drug specifically targeted at adrenocortical cancer and related diseases and plays an important role in controlling tumor growth and regulating hormone levels.

Reference materials:https://go.drugbank.com/drugs/DB00648